Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function [version 1; peer review: 3 approved]
Lipodystrophy is a disease characterized by a partial or total absence of adipose tissue leading to severe metabolic derangements including marked insulin resistance, type 2 diabetes, hypertriglyceridemia, and steatohepatitis. Lipodystrophy is also a source of major cardiovascular disorders which, i...
Main Authors: | Thiago Bruder-Nascimento, Taylor C. Kress, Eric J. Belin de Chantemele |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2019-10-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-1756/v1 |
Similar Items
-
Leptin therapy in lipodystrophy
Published: (2010-09-01) -
Leptin in Relation to the Lipodystrophy-Associated Metabolic Syndrome
by: Christos S. Mantzoros
Published: (2012-06-01) -
Serum Adiponectin and Leptin Levels in Patients with Lipodystrophies
Published: (2004-03-01) -
Causes of lipodystrophy
by: Katarzyna Korabiusz, et al.
Published: (2018-09-01) -
Familial Partial Lipodystrophy (FPLD): Recent Insights
by: Bagias C, et al.
Published: (2020-05-01)